We are live on ! Find out more
BRCM

Bright Rock Capital Management Portfolio holdings

AUM $499M
1-Year Est. Return 8.36%
This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+8.36%
3 Year Est. Return
+41.76%
5 Year Est. Return
+64.28%
10 Year Est. Return
+252.44%
AUM
$339M
AUM Growth
+$4.33M
Cap. Flow
-$2.28M
Cap. Flow %
-0.67%
Top 10 Hldgs %
23.61%
Holding
90
New
2
Increased
5
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$5.3M
2
TMO icon
Thermo Fisher Scientific
TMO
+$4.7M
3
ZTS icon
Zoetis
ZTS
+$4.43M
4
OII icon
Oceaneering
OII
+$1.4M
5
SLB icon
SLB Ltd
SLB
+$860K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.81M
2
NOV icon
NOV
NOV
+$5.97M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.28M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$936K
5
CTSH icon
Cognizant
CTSH
+$635K

Sector Composition

Rank Sector Weight
1 Healthcare 11.09%
2 Communication Services 11.01%
3 Industrials 9.23%
4 Financials 9.22%
5 Energy 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLO icon
76
Flowers Foods
FLO
$1.49B
$1.28M 0.38%
74,100
OII icon
77
Oceaneering
OII
$4.86B
$1.26M 0.37%
+55,000
New +$1.4M
FANG icon
78
Diamondback Energy
FANG
$57.1B
$1.25M 0.37%
14,100
MD icon
79
Pediatrix Medical
MD
$2.18B
$1.24M 0.37%
20,600
TSCO icon
80
Tractor Supply
TSCO
$16.1B
$1.06M 0.31%
97,500
ADI icon
81
Analog Devices
ADI
$179B
$700K 0.21%
9,000
MSM icon
82
MSC Industrial Direct
MSM
$6.89B
$666K 0.2%
7,750
ATR icon
83
AptarGroup
ATR
$8.55B
$651K 0.19%
7,500
VAR
84
DELISTED
Varian Medical Systems, Inc.
VAR
$619K 0.18%
6,000
MKC icon
85
McCormick & Company Non-Voting
MKC
$13.7B
$585K 0.17%
12,000
FTI icon
86
TechnipFMC
FTI
$28.6B
$544K 0.16%
26,880
DLTR icon
87
Dollar Tree
DLTR
$24.4B
$503K 0.15%
7,200
-4,000
-36% -$309K
CPAY icon
88
Corpay
CPAY
$25B
$476K 0.14%
3,300
GILD icon
89
Gilead Sciences
GILD
$162B
-115,000
Closed -$7.81M
NOV icon
90
NOV
NOV
$6.93B
-149,000
Closed -$5.97M

Similar funds

Bright Rock Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Bright Rock Capital Management held 90 positions worth $339M, up 1.3% from $335M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 4.4%. Bright Rock Capital Management opened 2 new positions and exited 2, leaving the 90-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 11% a quarter earlier, followed by Communication Services and Industrials.

  • Bright Rock Capital Management's largest Q2 2017 buy was Zoetis: 75,000 shares worth $4.68M.
  • Bright Rock Capital Management added most to Chevron in Q2 2017, an estimated $5.3M increase.
  • Bright Rock Capital Management's biggest Q2 2017 reduction was Johnson & Johnson, cutting an estimated $1.28M.
  • Bright Rock Capital Management fully exited Gilead Sciences in Q2 2017, selling an estimated $7.81M.
  • Bright Rock Capital Management's ten largest holdings make up 24% of its $339M portfolio in Q2 2017.
  • Bright Rock Capital Management opened 2 new positions and closed 2 in Q2 2017.
  • Bright Rock Capital Management's portfolio value rose 1.3% quarter-over-quarter to $339M.

Based on Bright Rock Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.